Ryan Leenay

Company: Eli Lilly

Job title: Associate Vice President, Gene Editing

Bio:

Ryan is the head of gene editing at Eli Lilly & Co, within the genetic medicine business unit. Lilly has internal programs and external editing partnerships with Scribe Therapeutics, Verve Therapeutics, and Precision Biosciences.

Seminars:

Panel Discussion: Ensuring Product Safety When Moving Into the Clinic 10:00 am

Outlining a checklist of necessary steps for comprehensively demonstrating product safety Practical steps for validating the specificity of a CRISPR/Cas therapy Safety experiments, analysis, and presentation to regulators to transition into the clinic Key considerations for product safety profiling with different delivery approachesRead more

day: Day 1 AM